- Carrum Health aims to help companies provide cancer care and surgeries for workers at a lower cost.
- The startup builds curated networks of doctors and surgeons who provide the care.
- Carrum used this presentation to raise a $45 million Series B led by OMERS Growth Equity.
The cost of healthcare in the US keeps on climbing, and the quality doesn't seem to be getting any better.
Carrum Health CEO Sach Jain is working to tackle both problems.
Founded in 2014, Carrum is focused on helping companies provide better healthcare for their workers at a lower cost. Carrum does this by curating a network of surgeons that companies can send their workers to for common procedures like hip and knee replacements. More recently, the company has expanded into cancer care, which is one of the costliest areas of healthcare for employers.
To keep growing the business and fuel the push into oncology, Carrum raised $45 million in a Series B round led by OMERS Growth Equity, the San Francisco-based startup said late last month. The investment brings Carrum's total funding to $96 million.
"This is the right time for us to expand that offering and scale it rapidly," Jain told Insider. "So that is the major area of focus for this round."
Read on to see the 17-slide presentation the company used to raise its Series B round and pitch investors on its approach. The company edited the deck to remove some confidential information.
Carrum works with employers to provide better surgery and cancer-care options for their workers.
The company says it offers a better approach than what's typical in US healthcare, where clinicians are paid for doing more procedures, not for the quality of care they provide.
Carrum focuses on people who need surgeries that can be scheduled ahead of time, since this gives the company an opportunity to match patients with its network of clinicians.
Carrum connects patients with top surgeons at a lower cost to their company. And the care comes with a warranty, so patients and their companies aren't on the hook for more costs if something goes wrong.
For surgeries, all care within 30 days of the procedure is covered for one set price. For cancer care, the upfront payment covers two years of treatment.
Patients themselves typically don't pay anything out of pocket. Carrum says its approach also benefits doctors by helping them increase the number of procedures they perform and get paid quickly.
A published study of Carrum's service found that it reduced costs and helped avoid unneeded procedures.
The way that Carrum pays for healthcare, known as bundled payments, has become increasing popular in the US as a way to improve quality and lower costs.
The company plans to expand its approach to more kinds of medical care over time. And the funding from the Series B round will help.
Carrum has partnered with other healthcare companies to make it easier for more people to use its service and to add their offerings, such as virtual care and cancer screenings, for its clients.
Carrum says employers spend $400 billion on surgeries and other complex care. Jain said his company is going after a market worth about $210 billion.
Carrum is highlighting for investors why it's focused on cancer care, an area it entered starting in 2021.
Among the cancers that Carrum provides care for are breast and thyroid cancer, as well as some blood cancers, a spokesperson said. The company is working to expand into more types of cancer.